Effects of Ang II and rosatan on expression and activity of MMP2 and MMP9 in cultured SMC from arteriole

Chinese Pharmacological Bulletin

Volumn 19, Issue 12, 2003, Pages 1345-1349

  Li, Yue Mei ^a   Feng, Da Ming ^a   Li, Yue Shan ^a,b   Wang, Shuang ^a   Yang, Yong Zong ^a   Wan, Zai Yang ^a  

^a UNIVERSITY OF SOUTH CHINA   (China)

^b GUANGZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Angiotensin II; Arteriole; Matrixmetalloproteinase 2; Matrixmetalloproteinase 9; Smooth muscle cells; Vascular remodeling

Indexed keywords

ANGIOTENSIN; GELATINASE A; GELATINASE B; LOSARTAN; MESSENGER RNA;

ANIMAL CELL; ARTERY MUSCLE; ARTICLE; CELL CULTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; NONHUMAN; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SMOOTH MUSCLE FIBER; WESTERN BLOTTING; ZYMOGRAPHY;

EID: 0346394226     PISSN: 10011978     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Zempo N, Koyama N, Richard DK et al. Regulation of vascular smooth muscle cell migration and proliferation in vitro and in injured rat arteries by a synthetic matrix metalloproteinase inhibitor. Arterioscler, Throm Vasc Biol, 1996;16(1):28-33
2. Bunkenburg B, Amelsvoort T, Rogg H et al. Receptor-mediated effects of angiotensin II on growth of vascular smooth muscle cells from spontaneously hypertensive rats. Hypertension, 1992;20(6):746-54
3. Pauly RR, Passaniti A, Bilato C et al. Migration of cultured vascular smooth muscle cells through a basement membrane barrier requires type IV collagenase activity and is inhibited by cellular differentiation. Circ Res, 1994;75(1):41-54
4. Gibbons GH, Dzau VJ. The emerging concept of vascular remodeling. N Engl J Med, 1994;330(20):1431-8
5. Saito S, Frank GD, Motley ED et al. Metalloproteinase inhibitor blocks angiotensin II-induced migration through inhibition of epidermal growth factor receptor transactivation. Biochem Biophys Res Commun. 2002;294(5):1023-9
6. Matsubara H. Pathophysiological role of angiotensin II type 2 receptor in cardiovascular and renal disease. Circ Res, 1998;83 (12):1182-91
7. Tsutsumi Y, Matsubara H, Masaki H et al. Angiotensin II type 2 receptor overexpression activates the vascular kinin system and causes vasodilation. J Clin Invest. 1999;104(7):925-35
8. 1 angiotensin-receptor blockade on structure and function of small arteries in SHR. J Cardiovasc Pharmacol, 1997;30(1):75-83